| CAT No: | CL-STZ-NO-01 |
| CAS No: | NA |
| Mol.F: | C21H31N3O2 |
| Mol.Wt.: | 357.5 |
| Chemical Name: | (1S,3aS,3bR,5aS,10aS,10bS,12aS)-1,10a,12a-trimethyl-7-nitroso-1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-ol |
| Inventory Status: | Custom synthesis |
This impurity is related to N-Nitroso Stanozolol is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
N-Nitroso Stanozolol is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(1S,3aS,3bR,5aS,10aS,10bS,12aS)-1,10a,12a-trimethyl-7-nitroso-1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-olCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Stanozolol Molecular Formula: C21H31N3O2
Molecular Weight: 357.5
Storage: Store in a cool, dry place.
| Product Name: | N-Nitroso Stanozolol |
| CAS No: | |
| Mol.F.: | C21H31N3O2 |
| Mol.Wt.: | 357.5 |
Cat. No: CL-STZ-01
CAS No: 10418-03-8
Mol. F: C21H32N2O
Mol. Wt: 328.5
Inv. Status: Custom Synthesis
Cat. No: CL-STZ-02
CAS No: 521-11-9
Mol. F: C20H32O2
Mol. Wt: 304.5
Inv. Status: Custom Synthesis
Cat. No: CL-STZ-03
CAS No: 434-07-1
Mol. F: C21H32O3
Mol. Wt: 332.5
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: